|
시장보고서
상품코드
2070329
대리모 출산 시장 규모와 예측(2021-2034년), 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 : 종류별, 의뢰 부모별, 진행 유형별, 기술별, 지역별Surrogacy Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Intended Parents, Journey Type, Technology, and Geography |
||||||
대리모 출산 시장은 2025년 53억 8,000만 달러에서 확대되어 2034년까지 119억 4,000만 달러에 달할 것으로 예측됩니다. 2026년부터 2034년까지 CAGR 9.3%를 기록할 것으로 전망됩니다.
대리모 출산 시장의 성장 요인으로는 의학적 불임이나 건강상의 이유로 인한 임신 장벽의 증가, 친권 확보를 위한 법적 규제 개혁의 진전, 그리고 다양한 가족 형태에 대한 사회적 수용이 높아지고 있는 점 등을 들 수 있습니다.
대리출산 시장이란, 대리모가 희망하는 부모를 대신하여 임신 및 출산을 수행하도록 대리출산을 주선하는 서비스, 기술 및 지원 체계를 의미합니다. 여기에는 불임 치료 클리닉, 대리모 중개 기관, 기증자 프로그램, 법률 및 상담 서비스는 물론, 관련 의료 및 행정적 지원이 포함됩니다. 대리모 출산 시장은 불임, 출산 지연, 동성 커플의 부모가 되고자 하는 욕구, 그리고 보조생식기술의 발전으로 인해 대안적인 생식 해결책을 찾는 개인, 커플 및 가족에게 서비스를 제공하고 있습니다.
북미의 대리모 출산 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미는 대리모 출산 시장을 주도하고 있으며, 부모를 지원하면서도 상업적, 이타적, 혹은 회색지대에 속하는 합의를 허용하는 다양한 법적 체계에 의해 형성되어 있습니다. 북미 전역에서 대리모 출산의 형태는 다양하며, 법적·의학적 측면이 국내외의 의뢰 부모 모두에게 매력적인 반면, 미국, 특히 캘리포니아주는 상업적 대리모 출산 분야의 선도적인 위치를 차지하고 있습니다. 이는 희망하는 부모의 혼인 상태나 성적 지향과 관계없이, 아이가 태어나기 전부터 희망하는 부모의 법적 친권을 확립하는 ‘출생 전 친권 명령’이 시행되고 있는 것도 한 가지 원인입니다. 2023년, 생식보조의료학회(SART)는 대리모를 통한 임신 주기가 총 1만 1,515건이었다고 보고했으며, 그 대부분에서 국제적인 관여가 확인되었습니다. 미국 거주자의 주기 수와 비교했을 때, 비미국 거주자의 대리모 임신 주기 수는 훨씬 더 많았습니다.
캐나다에서는 “생식보조의료법”에 의해 정의된 이타적인 대리모 출산의 틀이 있으며, 실비 상환을 초과하는 보수는 금지되어 있습니다. 그러나 퀘벡주 등 더 많은 주에서 법 개정이 진행되면서 대리모 계약의 구성요소가 명확해지고, 대리모가 친권을 포기하기 위해 필요한 법적 절차가 정의됨에 따라 대리모 출산에 대한 수요가 증가하고 있습니다. 멕시코에는 보조생식술에 관한 단일 연방법이 존재하지 않으며, 대리모 출산은 판례나 지역법에 따라 규제되고 있습니다. 입양을 희망하는 부모는 여전히 많은 경우, 시민상태등록소에 등록 절차를 밟아 법적 친권을 확립하기 위해 사법 절차를 이용해야 하며, 그 결과 입양을 희망하는 부모가 친권 관련 서류, 나아가 국적 관련 서류를 받기까지 상당한 지연이 발생하고 있습니다.
향후 시장 기회 창출을 위해 국내 이용을 촉진하기 위한 법적 조화와 규제 개혁의 가속화
대리 출산과 관련된 국경을 초월한 분쟁이 증가함에 따라, 친권 보장을 강화하고 생식 관광의 확산을 억제하기 위해 유럽 및 기타 지역에서 법제 조화를 위한 노력이 진행되고 있습니다. EU는 관할권 및 친권 인정에 관한 규제안을 통해 이러한 노력을 지원하고 있으며, 그 목적은 한 EU 회원국에서 확립된 친권을 다른 모든 EU 회원국이 자동으로 인정하는 체계를 구축하는 데 있습니다. 그 목적은 현재 희망하는 부모가 자국 이외의 지역에서 대리 출산을 하도록 조장하고 있는 법 제도의 파편화를 해소하는 데 있습니다. 국제적 차원에서 헤이그 국제사법회의는 아동의 정체성과 가족의 일원으로서의 권리를 보호하고, 모든 법역에서 국제적으로 일관된 지침을 확립하기 위한 수단으로서, 친권 인정에 관한 표준화된 접근 방식을 마련하고 있습니다.
또한, 대리모 출산과 관련하여 법을 개정하고 있는 국가도 많이 있습니다. 예를 들어, 덴마크는 2025년에 국내 및 국제 대리모 출산을 규제하는 법안을 통과시켰으며, 이 법안에는 관련된 모든 당사자에 대한 보다 엄격한 보호 기준이 포함되어 있습니다. 영국 법위원회는 임신 전 요건이 충족되는 한, 희망하는 부모가 출생 시 법적 친자관계를 확립할 수 있는 새로운 절차를 마련할 것을 제안하고 있지만, 관계자들의 로비 활동에도 불구하고 현재로서는 해당 법안이 의회에서 계류 중입니다. 미국에서는 “통일 친자관계법(Uniform Parentage Act)”의 개정이 진행되고 있으며, 각 주의 법률을 통일하는 한편, 전통적인 핵가족과는 다른 형태의 가족에게 더 이용하기 쉽고 공정한 선택지를 제공하는 것을 목적으로 하고 있습니다. 이러한 일련의 입법 노력을 통해 국내 차원의 법적 인정을 위한 예측 가능한 길이 마련되고 있으며, 그 결과 국제적인 대리모 계약의 필요성이 줄어들고, 전 세계 모든 법역에서 윤리 기준이 향상되고 아동 및 희망하는 부모에 대한 보호가 강화되고 있습니다.
목차
제1장 주요 요약
제2장 대리모 출산 시장 전망
제3장 경쟁 구도
제4장 대리모 출산 시장 : 주요 업계 역학
제5장 대리모 출산 시장 : 세계 시장 분석
제6장 대리모 출산 시장 매출 분석 : 유형별
제7장 대리모 출산 시장 매출 분석 : 의뢰 부모별
제8장 대리모 출산 시장 매출 분석 : 진행 유형별
제9장 대리모 출산 시장 매출 분석 : 기술별
제10장 대리모 출산 시장 : 지역별 분석
제11장 대리모 출산 시장 업계 상황
제12장 대리모 출산 시장 : 주요 기업 개요
제13장 부록
KSMThe Surrogacy Market is anticipated to grow from US$ 5.38 billion in 2025 and is projected to reach US$ 11.94 billion by 2034; it is expected to register a CAGR of 9.3% during 2026-2034.
The surrogacy market growth is attributed to rising medical infertility and health-related barriers to pregnancy, surging legal and regulatory reforms providing parentage certainty, and growing societal acceptance of diverse family structures.
The surrogacy market refers to the services, technologies, and support systems that facilitate surrogacy arrangements, where a surrogate carries a pregnancy on behalf of intended parents. It includes fertility clinics, surrogacy agencies, donor programs, legal and counseling services, and associated medical and administrative support. The surrogacy market serves individuals, couples, and families seeking alternative reproductive solutions, owing to infertility, delayed parenthood, same-sex parenthood, and advancements in assisted reproductive technologies.
The surrogacy market in North America is segmented into the US, Canada, and Mexico. North America is leading the surrogacy market, shaped by differing legal frameworks that accommodate commercial, altruistic, and grey-area arrangements while serving parents. While gestational surrogacy is widely varied across North America, with a variety of legal and medical aspects making it attractive to both domestic and international intended parents, the US has become a leader in commercial surrogacy, particularly in California, due in part to enforced pre-birth parentage orders that establish legal parentage for intended parents before their children are even born, regardless of the marital status or sexual orientation of the intended parents. In 2023, the Society for Assisted Reproductive Technology (SART) reported a total of 11,515 gestational carrier cycles, with a large percentage of international involvement; the number of gestational carrier cycles by non-U.S. residents was much higher compared with the number of cycles by US residents.
Canada has an altruistic framework for surrogacy defined by the Assisted Human Reproduction Act, which prohibits compensation beyond the reimbursement of out-of-pocket expenses. However, as more provincial legislative reforms, such as in Quebec, have clarified what constitutes a surrogacy agreement and defined the legal steps a surrogate must take to relinquish her parental rights, the demand for surrogacy is growing. There is no single federal law for assisted reproductive technology in Mexico; court cases and regional law govern surrogacy. Intended parents must still often use the judicial process to establish legal parentage through the process of registering at the Registry of Civil Status, which results in a long delay before intended parents receive documentation regarding parentage and therefore their citizenship.
Acceleration of Legal Harmonization and Regulatory Reforms to Increase Domestic Utilization to Provide Market Opportunities in Future
An increase in cross-border disputes related to Surrogacy is bringing legal harmonisation initiatives in Europe and beyond to assist in providing assurance over parental rights and reducing the prevalence of reproductive tourism. With these initiatives being supported by the EU through a proposed regulation concerning jurisdiction and the recognition of parentage, the aim is to create an automatic recognition of those parental rights established in one EU member state by every other member state of the EU. The goal is to eliminate the fragmentation that presently encourages intended parents to undertake surrogacy outside of their home country. At the international level, the Hague Conference on Private International Law is developing a standardised approach to the recognition of parentage as a means to protect the child's right to identity and being part of a family unit and to establish internationally consistent guidelines for all jurisdictions.
There are many countries also implementing legislative changes in relation to Surrogacy. For instance, Denmark passed legislation in 2025 regulating both domestic and international Surrogacy, which included stricter standards of protection for all parties involved. The UK Law Commission has proposed the establishment of a new process through which intended parents would attain a legal parentage at the time of birth as long as the pre-conception requirements are satisfied, however, as of yet, the legislation has stalled in Parliament despite lobbying efforts from interested parties. In the United States, revisions are taking place within the Uniform Parentage Act as an effort to bring state uniformity to the law as well as to provide more accessible and equitable options for families that are different than traditional nuclear families. Collectively, these legislative efforts are creating predictable paths to legal recognition at the domestic level thereby reducing the need for international surrogacy arrangements, increasing standards of ethics and protections to children as well as the intended parents in all jurisdictions worldwide.
The American Society for Reproductive Medicine (ASRM), Society for Assisted Reproductive Technology (SART), European Society of Human Reproduction and Embryology (ESHRE), Human Fertilisation and Embryology Authority, Hague Conference on Private International Law are among the primary and secondary sources referred to while preparing the surrogacy market report.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Surrogacy Market Landscape
- 2.1 Overview
- 2.2 Supply Chain Analysis
- 2.2.1 List of Manufacturers/Suppliers
- 2.3 Porter's Five Force Analysis
- 2.3.1 Bargaining Power of Suppliers: Moderate
- 2.3.2 Bargaining Power of Buyers: High
- 2.3.3 Threat of New Entrants: Moderate
- 2.3.4 Threat of Substitutes:
- 2.3.5 Competitive Rivalry: High
- 2.4 PEST Analysis
- 2.5 Impact of Artificial Intelligence (AI)
- 2.6 Regulatory Framework
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Share Analysis, 2025 - By Key Players
- 3.3 Market Concentration
4. Surrogacy Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Medical Infertility and Health-Related Barriers to Pregnancy
- 4.1.2 Increasing Progressive Legal and Regulatory Reforms Providing Parentage Certainty
- 4.1.3 Growing Societal Acceptance of Diverse Family Structures
- 4.2 Market Restraints
- 4.2.1 Altruistic-Only Compensation Limits and Resulting Surrogate Shortages
- 4.2.2 Fragmented Legal Frameworks and Delays in Parentage Establishment
- 4.2.3 Heavy Reliance on Cross-Border and Interstate Arrangements with Recognition Risks
- 4.3 Market Opportunities
- 4.3.1 Progressive Legal Reforms and Policy Reviews Expanding Eligibility and Parentage Certainty
- 4.3.2 Rising Demand from Diverse Family Structures and International Intended Parents
- 4.4 Future Trends
- 4.4.1 Acceleration of Legal Harmonization and Regulatory Reforms to Increase Domestic Utilization
- 4.4.2 Integration of Advanced Assisted Reproductive Technologies to Enhance Safety and Clinical Outcomes
- 4.4.3 Heightened Focus on Inclusivity for Diverse Families and Ethical Cross-Border Safeguards
- 4.5 Impact of Drivers and Restraints
5. Surrogacy Market - Global Market Analysis
- 5.1 Surrogacy Market Revenue (US$ Million), 2021-2034
- 5.2 Surrogacy Market Forecast and Analysis
6. Surrogacy Market Revenue Analysis - Type
- 6.1 Surrogacy Market Forecasts and Analysis by Type
- 6.1.1 Gestational
- 6.1.1.1 Overview
- 6.1.1.2 Gestational: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.2 Traditional
- 6.1.2.1 Overview
- 6.1.2.2 Traditional: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.1 Gestational
7. Surrogacy Market Revenue Analysis - Intended Parents
- 7.1 Surrogacy Market Forecasts and Analysis by Intended Parents
- 7.1.1 Heterosexual Intended Parents
- 7.1.1.1 Overview
- 7.1.1.2 Heterosexual Intended Parents: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 7.1.2 Single Parent
- 7.1.2.1 Overview
- 7.1.2.2 Single Parent: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 7.1.3 LGBTQ Parents
- 7.1.3.1 Overview
- 7.1.3.2 LGBTQ Parents: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 7.1.1 Heterosexual Intended Parents
8. Surrogacy Market Revenue Analysis - Journey Type
- 8.1 Surrogacy Market Forecasts and Analysis by Journey Type
- 8.1.1 Agency Supported Surrogacy Journeys
- 8.1.1.1 Overview
- 8.1.1.2 Agency Supported Surrogacy Journeys: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.2 Independent Surrogacy Journeys
- 8.1.2.1 Overview
- 8.1.2.2 Independent Surrogacy Journeys: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.1 Agency Supported Surrogacy Journeys
9. Surrogacy Market Revenue Analysis - Technology
- 9.1 Surrogacy Market Forecasts and Analysis by Technology
- 9.1.1 IVF
- 9.1.1.1 Overview
- 9.1.1.2 IVF: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 9.1.2 Artificial Insemination
- 9.1.2.1 Overview
- 9.1.2.2 Artificial Insemination: Surrogacy Market - Revenue, 2021-2034 (US$ Million)
- 9.1.1 IVF
10. Surrogacy Market - Geographical Analysis
- 10.1 North America
- 10.1.1 North America Surrogacy Market Overview
- 10.1.2 North America: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.3 North America: Surrogacy Market - By Segmentation
- 10.1.3.1 Type
- 10.1.3.2 Intended Parents
- 10.1.3.3 Journey Type
- 10.1.3.4 Technology
- 10.1.4 North America: Surrogacy Market Breakdown by Countries
- 10.1.4.1 United States Market
- 10.1.4.1.1 United States: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.1.2 United States: Surrogacy Market - By Segmentation
- 10.1.4.1.2.1 Type
- 10.1.4.1.2.2 Intended Parents
- 10.1.4.1.2.3 Journey Type
- 10.1.4.1.2.4 Technology
- 10.1.4.2 Canada Market
- 10.1.4.2.1 Canada: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.2.2 Canada: Surrogacy Market - By Segmentation
- 10.1.4.2.2.1 Type
- 10.1.4.2.2.2 Intended Parents
- 10.1.4.2.2.3 Journey Type
- 10.1.4.2.2.4 Technology
- 10.1.4.3 Mexico Market
- 10.1.4.3.1 Mexico: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.3.2 Mexico: Surrogacy Market - By Segmentation
- 10.1.4.3.2.1 Type
- 10.1.4.3.2.2 Intended Parents
- 10.1.4.3.2.3 Journey Type
- 10.1.4.3.2.4 Technology
- 10.1.4.1 United States Market
- 10.2 Europe
- 10.2.1 Europe Surrogacy Market Overview
- 10.2.2 Europe: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.3 Europe: Surrogacy Market - By Segmentation
- 10.2.3.1 Type
- 10.2.3.2 Intended Parents
- 10.2.3.3 Journey Type
- 10.2.3.4 Technology
- 10.2.4 Europe: Surrogacy Market Breakdown by Countries
- 10.2.4.1 United Kingdom Market
- 10.2.4.1.1 United Kingdom: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.1.2 United Kingdom: Surrogacy Market - By Segmentation
- 10.2.4.1.2.1 Type
- 10.2.4.1.2.2 Intended Parents
- 10.2.4.1.2.3 Journey Type
- 10.2.4.1.2.4 Technology
- 10.2.4.2 Russia Market
- 10.2.4.2.1 Russia: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.2.2 Russia: Surrogacy Market - By Segmentation
- 10.2.4.2.2.1 Type
- 10.2.4.2.2.2 Intended Parents
- 10.2.4.2.2.3 Journey Type
- 10.2.4.2.2.4 Technology
- 10.2.4.3 Netherlands Market
- 10.2.4.3.1 Netherlands: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.3.2 Netherlands: Surrogacy Market - By Segmentation
- 10.2.4.3.2.1 Type
- 10.2.4.3.2.2 Intended Parents
- 10.2.4.3.2.3 Journey Type
- 10.2.4.3.2.4 Technology
- 10.2.4.4 Ukraine Market
- 10.2.4.4.1 Ukraine: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.4.2 Ukraine: Surrogacy Market - By Segmentation
- 10.2.4.4.2.1 Type
- 10.2.4.4.2.2 Intended Parents
- 10.2.4.4.2.3 Journey Type
- 10.2.4.4.2.4 Technology
- 10.2.4.5 Greece Market
- 10.2.4.5.1 Greece: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.5.2 Greece: Surrogacy Market - By Segmentation
- 10.2.4.5.2.1 Type
- 10.2.4.5.2.2 Intended Parents
- 10.2.4.5.2.3 Journey Type
- 10.2.4.5.2.4 Technology
- 10.2.4.6 Rest of Europe Market
- 10.2.4.6.1 Rest of Europe: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.6.2 Rest of Europe: Surrogacy Market - By Segmentation
- 10.2.4.6.2.1 Type
- 10.2.4.6.2.2 Intended Parents
- 10.2.4.6.2.3 Journey Type
- 10.2.4.6.2.4 Technology
- 10.2.4.1 United Kingdom Market
- 10.3 Asia Pacific
- 10.3.1 Asia Pacific Surrogacy Market Overview
- 10.3.2 Asia Pacific: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.3 Asia Pacific: Surrogacy Market - By Segmentation
- 10.3.3.1 Type
- 10.3.3.2 Intended Parents
- 10.3.3.3 Journey Type
- 10.3.3.4 Technology
- 10.3.4 Asia Pacific: Surrogacy Market Breakdown by Countries
- 10.3.4.1 Australia Market
- 10.3.4.1.1 Australia: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.1.2 Australia: Surrogacy Market - By Segmentation
- 10.3.4.1.2.1 Type
- 10.3.4.1.2.2 Intended Parents
- 10.3.4.1.2.3 Journey Type
- 10.3.4.1.2.4 Technology
- 10.3.4.2 Georgia Market
- 10.3.4.2.1 Georgia: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.2.2 Georgia: Surrogacy Market - By Segmentation
- 10.3.4.2.2.1 Type
- 10.3.4.2.2.2 Intended Parents
- 10.3.4.2.2.3 Journey Type
- 10.3.4.2.2.4 Technology
- 10.3.4.3 India Market
- 10.3.4.3.1 India: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.3.2 India: Surrogacy Market - By Segmentation
- 10.3.4.3.2.1 Type
- 10.3.4.3.2.2 Intended Parents
- 10.3.4.3.2.3 Journey Type
- 10.3.4.3.2.4 Technology
- 10.3.4.4 Thailand Market
- 10.3.4.4.1 Thailand: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.4.2 Thailand: Surrogacy Market - By Segmentation
- 10.3.4.4.2.1 Type
- 10.3.4.4.2.2 Intended Parents
- 10.3.4.4.2.3 Journey Type
- 10.3.4.4.2.4 Technology
- 10.3.4.5 Vietnam Market
- 10.3.4.5.1 Vietnam: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.5.2 Vietnam: Surrogacy Market - By Segmentation
- 10.3.4.5.2.1 Type
- 10.3.4.5.2.2 Intended Parents
- 10.3.4.5.2.3 Journey Type
- 10.3.4.5.2.4 Technology
- 10.3.4.6 Rest of Asia Pacific Market
- 10.3.4.6.1 Rest of Asia Pacific: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.6.2 Rest of Asia Pacific: Surrogacy Market - By Segmentation
- 10.3.4.6.2.1 Type
- 10.3.4.6.2.2 Intended Parents
- 10.3.4.6.2.3 Journey Type
- 10.3.4.6.2.4 Technology
- 10.3.4.1 Australia Market
- 10.4 Rest of the Word
- 10.4.1 Rest of the World Surrogacy Market Overview
- 10.4.2 Rest of the World: Surrogacy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.3 Rest of the World: Surrogacy Market - By Segmentation
- 10.4.3.1 Type
- 10.4.3.2 Intended Parents
- 10.4.3.3 Journey Type
- 10.4.3.4 Technology
11. Surrogacy Market Industry Landscape
12. Surrogacy Market - Key Company Profiles
- 12.1 Circle Surrogacy LLC
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 ConceiveAbilities
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 San Diego Fertility Center
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 IARC
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Genea Fertility
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Monash IVF Group Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 ACRC Global
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Growing Generations
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Brilliant Beginnings
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Boston IVF
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 Eva
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
13. Appendix
- 13.1 Glossary
- 13.2 Research Methodology and Approach
- 13.2.1 Secondary Research
- 13.2.2 Primary Research
- 13.2.3 Market Estimation Approach
- 13.2.3.1 Supply Side Analysis
- 13.2.3.2 Demand Side Analysis
- 13.2.4 Research Assumptions and Limitations
- 13.2.5 Currency Conversion
- 13.3 About The Insight Partners
- 13.4 Market Intelligence Cloud
